CENTOGENE GmbH

CENTOGENE was founded in 2006 and has since been dedicated to the highest quality genetic and biochemical diagnostic testing for the global medical community. We believe that the molecular understanding of rare disease allows for the coordination of personalized and focused therapy and improved control of rare and congenital disease. This is being supported by the development of very specific and sensitive biomarkers. As one of the world's leading companies in molecular diagnostics, we also support clinicians with expert genetic counseling services and newborn screening. We deliver complete solutions for your rare disease diagnostics.

Visit out website www.centogene.com for more details